CRISPR/Cas9系统——靶向基因组编辑的新策略  

The CRISPR/Cas9 system:A novel strategy for targeted genome engineering

作　　者：赵海卫[1] 吕欣[1] 尹文[2] 

机构地区：[1]第四军医大学微生物学教研室,陕西西安710032 [2]第四军医大学西京医院输血科

出　　处：《中国病原生物学杂志》2015年第3期281-284,共4页Journal of Pathogen Biology

基　　金：国家自然科学基金项目(No.81171637);陕西省科技统筹创新工程计划(No.2014KTCL03-08);军队后勤计划项目(CWS13L058)

摘　　要：CRISPR/Cas系统是细菌和古细菌在长期演化过程中形成的一种适应性免疫防御系统。Ⅱ型CRISPR/Cas系统经人工改造为由Cas9核酸酶和特异的sgRNA构成的新型靶向基因组编辑技术,即CRISPR/Cas9系统。与锌指核酸酶(ZFNs)、转录激活子样效应因子核酸酶(TALENs)相比,CRISPR/Cas9系统操作简单,花费低,编辑功能更强。本文综述了CRISPR/Cas9系统的基本结构、作用机制和应用进展,并对其应用前景进行了展望。CRISPR/Cas is an adaptive immune defense system that is formed as bacteria and archaea evolve over the long term.CRISPR/Cas9 is a novel technique for targeted genome engineering.Derived from the type II CRISPR/Cas nuclease system,CRISPR/Cas9 consists of specific sgRNA,which recognizes target nucleic acids via Watson-Crick base pairing,and cas9 nuclease,which cleaves target nucleic acids.Compared to previous targeted genome-editing techniques like ZFNs and TALENs,the CRISPR/Cas9 system has the advantages of easier manipulation,low cost,and enhanced editing capability.This review describes the genomic structure of the CRISPR/Cas system and this review summarizes its mechanism and recent advances in the use of CRISPR/Cas9 as well as prospects for its future use.

关 键 词：CRISPR/Cas9系统 靶向基因组编辑 分子靶向治疗 脱靶效应 综述 

分 类 号：R37[医药卫生—病原生物学]